NCT03073967: An ongoing trial by AiCuris Anti-infective Cures AG
This trial is ongoing. It must report results 8 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03073967 |
|---|---|
| Title | A Randomized, Open Label, Multi-center, Comparative Trial, to Assess the Efficacy and Safety of Pritelivir for the Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects (PRIOH-1) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 8, 2017 |
| Completion date | Aug. 15, 2025 |
| Required reporting date | Aug. 15, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 3, 2025 |
| Days late | None |